Here are the 10-Q quarterly reports from Hillenbrand, Inc. (HI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HI filings page.
Hillenbrand, Inc. reported weaker results for the three months ended December 31, 2025, as it reshapes the portfolio and prepares to go private. Net revenue fell to $550.2 million from $706.9 million, mainly due to lower capital equipment demand and the divestiture of the Milacron injection molding and extrusion business.
Consolidated net income was $1.0 million, with a net loss attributable to Hillenbrand of $2.2 million, or $(0.03) per share, versus earnings of $0.09 a year earlier. Adjusted EBITDA declined to $62.1 million from $97.1 million, driven by lower volume and cost inflation, partly offset by pricing and productivity gains.
Advanced Process Solutions revenue decreased 9% to $463.6 million, while Molding Technology Solutions revenue dropped 56% to $86.6 million, largely from the Milacron sale. Debt totaled $1.58 billion and cash and cash equivalents $173.1 million, with $400.7 million of revolver capacity, of which $34.5 million was available under the tightest covenant.
The company is being acquired by an affiliate of Lone Star Funds XII, L.P. Each share of common stock will be converted into $32.00 in cash, following shareholder approval on January 8, 2026. The merger is expected to close by the end of the first quarter of calendar 2026, subject to customary conditions.
Hillenbrand, Inc. reported revenue compression for the quarter and year-to-date as the company re-shaped its portfolio through divestitures. Net revenue for the three months ended June 30, 2025 was $598.9 million, down from $786.6 million a year earlier; nine-month revenue was $2,021.7 million versus $2,345.2 million. Gross profit declined to $202.6 million for the quarter.
The company recorded positive consolidated net income of $4.1 million for the quarter (income attributable to Hillenbrand of $1.9 million, or $0.03 per share) compared with a large loss in the prior-year quarter. For the nine months, consolidated net loss was $25.6 million. Hillenbrand completed the March 31, 2025 divestiture of a majority interest in Milacron, receiving total consideration of $286.0 million (comprised of $98.0 million cash and $188.0 million of debt assumed by the buyer), recorded an initial equity method investment of $68.7 million, and recognized a loss on divestiture of $56.1 million year-to-date. In a subsequent event, Hillenbrand sold its TerraSource interest on July 1, 2025 for $245.0 million and expects a pre-tax gain of approximately $66.0 million, subject to adjustments. Total assets declined to $4,676.5 million and total liabilities to $3,324.3 million at June 30, 2025.